###begin article-title 0
###xml 66 73 66 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Interferon-gamma coordinates CCL3-mediated neutrophil recruitment in vivo
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 77 100 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 102 105 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 223 226 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
We have shown previously that acute infection with the respiratory pathogen, pneumonia virus of mice (PVM), results in local production of the proinflammatory chemokine, CCL3, and that neutrophil recruitment in response to PVM infection is reduced dramatically in CCL3 -/- mice.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 365 372 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 156 159 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 229 233 <span type="species:ncbi:10090">mice</span>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
###xml 403 406 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 669 673 <span type="species:ncbi:10090">mice</span>
In this work, we demonstrate that CCL3-mediated neutrophil recruitment is coordinated by interferon-gamma (IFNgamma). Neutrophil recruitment in response to PVM infection was diminished five-fold in IFNgamma receptor gene-deleted mice, although neutrophils from IFNgammaR -/- mice expressed transcripts for the CCL3 receptor, CCR1 and responded functionally to CCL3 ex vivo. Similarly, in the absence of PVM infection, CCL3 overexpression alone could not elicit neutrophil recruitment in the absence of IFNgamma. Interestingly, although supplemental IFNgamma restored neutrophil recruitment and resulted in a sustained weight loss among CCL3-overexpressing IFNgamma -/- mice, CCL3-mediated neutrophil recruitment alone did not result in the pulmonary edema or respiratory failure characteristic of severe viral infection, suggesting that CCL3 and IFN-gamma together are sufficient to promote neutrophil recruitment but not pathologic activation.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 186 193 178 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Our findings reveal a heretofore unrecognized hierarchical interaction between the IFNgamma and CCL3, which demonstrate that IFNgamma is crucial for CCL3-mediated neutrophil recruitment in vivo.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 296 297 296 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Most respiratory virus infections are relatively benign and self-limited events. However, infection with highly pathogenic viruses can result in more severe sequelae, in which disease progresses to respiratory failure due to uncontrolled inflammation, pulmonary edema, and damage to lung tissue [1-5].
###end p 9
###begin p 10
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 298 313 298 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Paramyxoviridae</italic>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 488 489 488 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 910 912 910 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 913 915 913 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1122 1124 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1221 1223 1217 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1405 1407 1401 1403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1408 1410 1404 1406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1514 1516 1510 1512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 182 205 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 207 210 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 269 272 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 342 369 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 371 374 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 758 761 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 866 869 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 895 900 <span type="species:ncbi:9606">human</span>
###xml 901 908 <span type="species:ncbi:9606">infants</span>
###xml 1042 1045 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 1127 1131 <span type="species:ncbi:10090">mice</span>
###xml 1499 1502 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
As part of an ongoing effort to understand inflammatory responses during severe respiratory virus infection, we have developed an inhalation model using the natural rodent pathogen, pneumonia virus of mice (PVM). Originally identified by Horsfall and colleagues [6,7], PVM is a pneumovirus (family Paramyxoviridae) that is closely related to respiratory syncytial virus (RSV), and is among the few characterized mouse models of virus-induced acute respiratory distress syndrome (ARDS) [7-9]. Among the prominent features of this infection, a minimal intranasal inoculum (30 - 100 pfu) results in robust virus replication within bronchial epithelial cells that is accompanied by profound granulocyte recruitment. In the absence of pharmacologic intervention, PVM infection progresses to pulmonary edema and respiratory compromise, similar to the more severe forms of RSV infection experienced by human infants [10,11]. In our earlier studies, we identified the chemokine CCL3 (MIP-1alpha) as a crucial component of this inflammatory response. PVM not only elicits production of CCL3 by infected bronchial epithelial cells [12], mice devoid of CCL3 or its receptor, CCR1, recruit dramatically fewer neutrophils to airways [13]. Blockade of the CCL3/CCR1 proinflammatory signaling pathway in conjunction with antiviral therapy resulted in improved survival in response to an otherwise lethal virus inoculum [14,15]. As CCL3 is only one of several major pro-inflammatory signaling pathways activated by PVM infection [12], there is certainly the possibility of additive, synergistic, or hierarchical means to promote and to amplify the ongoing inflammatory response.
###end p 10
###begin p 11
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 299 301 287 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 302 304 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 386 388 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 389 391 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 491 493 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 494 496 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 696 698 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 699 701 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 785 787 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 788 790 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 791 793 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 70 83 <span type="species:ncbi:11034">Sindbis virus</span>
###xml 277 280 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 290 297 <span type="species:ncbi:9606">infants</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 478 481 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 652 655 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 770 773 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Although first identified as a component of the antiviral response to Sindbis virus [16], the role of the Th1 cytokine, interferon-gamma (IFNgamma) in pneumovirus infection remains uncertain. IFNgamma is readily detected in bronchoalveolar lavage fluid and nasal washings from RSV-infected infants [17,18], and minimal or absent response has been correlated with poor clinical outcome [19-24]. IFNgamma is also detected in BAL fluid of BALB/c mice in response to challenge with RSV virions [25,26] and plays a role in limiting the inflammatory response to secondary challenge and in generating the allergic histopathology in response to formalin-fixed RSV vaccine antigens and virion components [27,28]. Likewise, local production of IFNgamma is a prominent response to PVM infection [12,29,30], although its role in modulating the primary inflammatory response has not yet been fully explored.
###end p 11
###begin p 12
###xml 288 295 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 95 98 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
In this manuscript, we explore the role of IFNgamma in modulating the inflammatory response to PVM infection, and utilize overexpression analysis to begin a dissection of the independent and interdependent contributions of both IFN-gamma and CCL3 to the process of neutrophil recruitment in vivo.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 59 62 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Microarray profiling of IFNgamma expression in response to PVM infection
###end title 14
###begin p 15
###xml 129 131 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 382 384 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 693 694 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 999 1001 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1023 1025 995 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 114 117 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 174 177 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 463 468 <span type="species:ncbi:10090">mouse</span>
###xml 984 987 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 1144 1147 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
Transcript encoding the cytokine IFNgamma was detected in mouse lung tissue at various time points in response to PVM infection [12]. In response to a non-lethal inoculum of PVM strain J3666, IFNgamma mRNA was detected above baseline levels beginning on day 5. IFN-gamma mRNA levels peak at day 7 after inoculation, and fall rapidly to baseline between days 7 - 14. Shown in Figure 1A are profiles of the 203 transcripts (of total 45,101 transcripts on the 430_2 mouse chip) that display kinetic expression correlations of 0.900 or greater with the IFN-gamma profile, as per the 'find similar' algorithm of Genespring GX 7.3. Selected transcripts, categorized by function, are listed in Table 1. Among the transcripts that correlate with the IFNgamma profile are 17 characterized interferon-response genes. Most intriguing is the close correlation (0.965) between the expression patterns of IFNgamma and CCL3 (MIP-1alpha). CCL3 is essential for granulocyte recruitment in response to PVM infection [13]. As shown in Figure 1B, there is a significant correlation between levels of immunoreactive IFNgamma and CCL3 in lung tissue from individual PVM-infected mice.
###end p 15
###begin p 16
###xml 0 125 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) Expression of transcripts in mouse lung tissue in response to PVM infection: IFN-&#947; and IFN-&#947; correlating profiles</bold>
###xml 656 740 640 720 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) Correlation of IFN-&#947; and CCL3 protein levels in individual PVM-infected mice</bold>
###xml 908 910 880 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 896 963 872 935 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) IFN&#947;<sup>+ </sup>NK and T cells detected in lungs of PVM-infected mice</bold>
###xml 983 985 951 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 998 1000 966 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1016 1018 984 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
###xml 66 69 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 590 593 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 723 726 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 822 826 <span type="species:ncbi:10090">mice</span>
###xml 869 872 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 946 949 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 959 963 <span type="species:ncbi:10090">mice</span>
###xml 1092 1095 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
(A) Expression of transcripts in mouse lung tissue in response to PVM infection: IFN-gamma and IFN-gamma correlating profiles. Baseline expression in uninfected mice (day 0) is set at 1.0 and normalized expression (per gene, per chip) is shown for days 1 - 7, 10, 14, 21 and 28 after inoculation. Profiles of 203 transcripts with patterns that correlate with that the profile of IFN-gamma (0.900 to 0.969) are shown in yellow to red, respectively, and identified by name in Table 1. The expression profile of CCL3 (MIP-1alpha), a chemokine crucial for neutrophil recruitment in response to PVM infection, is overdrawn with a blue line (correlation 0.965). (B) Correlation of IFN-gamma and CCL3 protein levels in individual PVM-infected mice. IFN-gamma and CCL3 detected by ELISA in lung tissue homogenates from individual mice days 0 - 28 after inoculation with 30 pfu PVM (n = 43) are as shown. (C) IFNgamma+ NK and T cells detected in lungs of PVM-infected mice. Total and IFNgamma+ NK cells, CD4+ T cells, and CD8+ T cells (+/- sd) detected per lung on day 6 after inoculation with 10 pfu PVM.
###end p 16
###begin p 17
###xml 53 56 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
Expression profiles that correlate with IFN-gamma in PVM-infected mouse lung tissue.
###end p 17
###begin p 18
The microarray analysis software package, Genespring GX 7.3 'find similar' function was used to inspect all transcript profiles for patterns related to that displayed by IFN-gamma. The minimum correlation considered to be similar was set at 0.900 (see Figure 1A).
###end p 18
###begin title 19
###xml 18 20 14 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 38 41 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Detection IFNgamma+ NK and T cells in PVM infected lung tissue
###end title 19
###begin p 20
###xml 23 25 19 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 49 51 45 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 58 60 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 230 232 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 273 275 269 271 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 390 391 378 379 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 394 396 382 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 430 432 416 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 455 457 441 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 525 527 509 511 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 601 603 579 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 131 134 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 205 208 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
Both total and IFNgamma+ subsets of NK cells, CD4+ and CD8+ T cells were enumerated in single cell suspensions of lung tissue from PVM-infected BALB/c mice evaluated at day 6 after inoculation with 10 pfu PVM strain J3666 [Figure 1C]. Only a small fraction (<2%) of the CD4+ T cells detected at this time point stained positively for IFNgamma, in contrast to the larger fraction of IFNgamma+CD8+ T cells detected (9.9 +/- 0.6 x 103 cells, 11% of total CD8+ T cells). Interestingly, 23% of the total NK cells (3.4 +/- 0.9 x 103 cells) stained positively for IFNgamma, an increase from 0.3 +/- 0.08 x 103 cells, or 4% of the total NK cells detected in a single lung from uninfected mice (data not shown).
###end p 20
###begin title 21
###xml 32 35 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
IFNgamma-dependent responses to PVM infection
###end title 21
###begin p 22
###xml 257 259 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 497 499 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 885 887 857 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1295 1296 1259 1260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 1299 1301 1263 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1341 1343 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1344 1346 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1515 1517 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 61 65 <span type="species:ncbi:10090">mice</span>
###xml 85 88 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 244 248 <span type="species:ncbi:10090">mice</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 601 604 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 632 636 <span type="species:ncbi:10090">mice</span>
###xml 863 866 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 932 935 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 984 988 <span type="species:ncbi:10090">mice</span>
###xml 1208 1212 <span type="species:ncbi:10090">mice</span>
###xml 1502 1506 <span type="species:ncbi:10090">mice</span>
Wild type and IFNgamma receptor gene deleted (IFNgammaR -/-) mice were infected with PVM and various parameters relating to the inflammatory response were assessed. Neutrophil recruitment to the airways was markedly diminished in IFNgammaR -/- mice [Figure 2A], reduced from 54 +/- 11 per 10 hpfs among wild type to 10 +/- 1.3 hpfs among IFNgammaR -/- mice, as determined on cytospin preparations of cells in BAL fluid (p < 0.001). These findings are consistent with those of Frey and colleagues [30], who described reduced inflammation in association with reduced IFNgamma production in the lungs of PVM infected, T-cell deficient mice. Given our earlier studies on the essential role of CCL3 in eliciting neutrophil recruitment, it is interesting to note that the absence of IFNgamma signaling had no impact on local production of this chemokine in response to PVM infection [Figure 2B]. IFNgamma was also detected in response to PVM infection in both wild type and in IFNgammaR-/- mice, albeit at higher levels among the latter group, most likely due to the absence of feedback inhibition (data not shown). The diminished neutrophil recruitment, while significant, was not as profound as that observed in mice subjected to complete blockade of CCL3-mediated signaling, in which we observed 104-105 fold-diminished neutrophil recruitment [14,15]. As might be anticipated from the diminished inflammatory response, we observe a statistically significant increase in virus titer among the IFNgammaR-/- mice [Figure 2C], although this difference is likewise not as dramatic as that observed in response to complete blockade of CCL3 signaling.
###end p 22
###begin p 23
###xml 0 97 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Neutrophil recruitment in response to PVM infection is diminished in IFN-&#947;R gene-deleted mice</bold>
###xml 99 103 95 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 197 201 193 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 244 248 240 244 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 38 41 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 93 97 <span type="species:ncbi:10090">mice</span>
Neutrophil recruitment in response to PVM infection is diminished in IFN-gammaR gene-deleted mice. (A) Neutrophils detected in BAL fluid 5 days after inoculation; hpf, high power field; *p < 0.001;(B) Detection of CCL3 in BAL fluid; *p < 0.001 (C) Virus copy number detected in lung tissue determined by quantitative RT-PCR.
###end p 23
###begin title 24
###xml 77 81 <span type="species:ncbi:10090">mice</span>
Receptor expression and responses of neutrophils from IFNgammaR gene-deleted mice
###end title 24
###begin p 25
###xml 274 276 270 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 572 574 564 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 249 253 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
As part of an initial attempt to determine whether neutrophils from IFNgammaR -/- mice were capable of responding to CCL3, we explored receptor expression and ligand-mediated calcium flux in neutrophils isolated from both gene-deleted and wild type mice. As shown in Figure 3A, both wild type and IFNgammaR-/- neutrophils express transcripts encoding CCR1, the major receptor for CCL3; no significant difference in absolute copy number was determined. Likewise, CCL3 induced dose-dependent intracellular calcium flux in both gene-deleted and wild type neutrophils [Figure 3B], demonstrating that neutrophils from IFNgammaR-/- mice have the innate capacity to respond to this chemoattractant ligand; the EC50s and maximum calcium fluxes detected were indistinguishable between the wild type and gene-deleted strains.
###end p 25
###begin p 26
###xml 0 62 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of wild type and IFN&#947;R gene-deleted neutrophils</bold>
###xml 64 68 60 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 275 279 267 271 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
Comparison of wild type and IFNgammaR gene-deleted neutrophils. (A) Expression of CCR1 transcript in wild type and IFNgammaR gene-deleted neutrophils (n = 9 and 6 independent samples, respectively) determined by quantitative RT-PCR; horizontal line denotes mean copy number. (B) Calcium flux (RFU) measured in response to increasing concentrations (0 - 500 nM) of CCL3.
###end p 26
###begin title 27
Overexpression of CCL3
###end title 27
###begin p 28
###xml 131 138 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 189 196 185 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 251 253 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 351 353 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 427 429 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 541 543 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 336 339 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 489 493 <span type="species:ncbi:10090">mice</span>
In order to examine the independent and interdependent contributions of CCL3 and IFNgamma to the process of neutrophil recruitment in vivo, we generated a method for overexpression of CCL3 in vivo. CCL3 was detected in lung tissue homogenates [Figure 4A], reaching levels similar to those detected in lung tissue of mice in response to PVM infection [12]. Immunoreactive CCL3 was detected in bronchial epithelial cells [Figure 4B]. No CCL3-positive cells were detected in lung tissue from mice challenged with control vector (vctrl) [Figure 4C].
###end p 28
###begin p 29
###xml 0 46 0 46 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Heterologous expression of CCL3 in mouse lungs</bold>
###xml 48 52 48 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 236 240 236 240 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 375 379 375 379 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 257 261 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
Heterologous expression of CCL3 in mouse lungs. (A) Detection of immunoreactive CCL3 in lungs of mice on day 9 after challenge via intranasal inoculation with the CCL3 overexpression vector (vCCL3) or control vector (vctrl), *p < 0.01. (B) Lung tissue from mice challenged with vCCL3, immunohistochemical localization of CCL3 within bronchiolar epithelial cells (at arrows), (C) Lung tissue from mice challenged with vctrl.
###end p 29
###begin title 30
Inflammatory responses to IFNgamma and CCL3
###end title 30
###begin p 31
###xml 177 179 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 687 689 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 1027 1029 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 1187 1189 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 771 775 <span type="species:ncbi:10090">mice</span>
###xml 1082 1086 <span type="species:ncbi:10090">mice</span>
We examined neutrophil recruitment in response to CCL3 overexpression in IFNgamma gene-deleted mice (IFNgamma -/-) with and without IFNgamma supplementation. As shown in Figure 5A, few neutrophils are detected in BAL fluid at baseline (vctrl) and no recruitment over baseline is observed in response to IFNgamma alone. Likewise, overexpression of CCL3 in the absence of IFNgamma does not elicit neutrophil recruitment. Neutrophil recruitment (~10 - fold over baseline) was observed in response to CCL3 expression only in the presence of IFNgamma. At the microscopic level, no inflammation was observed in lung tissue of IFNgamma -/- mice in response to CCL3 overexpression alone [Figure 5B]. In contrast, significant pathology was observed in lung tissue of IFNgamma -/- mice expressing CCL3 and supplemented with exogenous IFNgamma. Findings include moderate peribronchiolar granulocytic infiltration and substantial parenchymal involvement but minimal edema fluid within the bronchioles and in the parenchymal tissue [Figure 5C]. Interestingly, weight loss is sustained among the mice overexpressing CCL3 while receiving supplemental IFNgamma over the 9 day examination period [Figure 5D], but, despite the substantial inflammatory response, we observe no progression to respiratory failure up to and including t = 14 days.
###end p 31
###begin p 32
###xml 0 84 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Neutrophil recruitment in response to CCL3 is ablated in IFN-&#947; gene-deleted mice</bold>
###xml 86 90 82 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 425 432 401 408 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, C) </bold>
###xml 506 510 478 482 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 525 529 497 501 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 647 651 615 619 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 80 84 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 485 489 <span type="species:ncbi:10090">mice</span>
Neutrophil recruitment in response to CCL3 is ablated in IFN-gamma gene-deleted mice. (A) Neutrophils detected in BAL fluid of IFNgamma gene-deleted (IFNgamma -/-) mice (+vctrl +med (medium; RPMI + 10% FCS vehicle control); open bar), + IFNgamma (+vctrl + IFNgamma, grey-shaded bar), +vCCL3 +med (black bar), or +vCCL3 + IFNgamma (black-shaded bar); *p < 0.01 vs. other conditions, day 9 after challenge with vCCL3 or vctrl. (B, C) Microscopic images of lung tissue from IFN-gamma -/- mice challenged with (B) vCCL3 + med or (C) vCCL3 + IFNgamma; original magnification, 20x. Inset, original magnification 63x, documenting neutrophil recruitment. (D) Change in body weight in response to CCL3 overexpression +/- IFN-gamma; *p < 0.01 at time points shown.
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 420 444 420 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cryptococcus neoformans </italic>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 177 180 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 280 285 <span type="species:ncbi:10090">mouse</span>
###xml 420 432 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 420 443 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
In previous work, we demonstrated that the actions of the chemokine, CCL3, signaling via its receptor CCR1, were crucial for granulocyte recruitment to the lungs in response to PVM infection [13-15]; CCL3 has also been shown to be a crucial mediator of granulocyte recruitment in mouse models of influenza [31]. Paradoxically, CCL3 gene-deletion results in augmented neutrophil and eosinophil recruitment in response to Cryptococcus neoformans infection [32]. Here we show that CCL3-mediated neutrophil recruitment depends directly on IFNgamma signaling, both in the setting of acute virus infection and in response to heterologous CCL3 expression in the respiratory epithelium.
###end p 34
###begin p 35
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 611 613 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 648 650 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 577 580 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
###xml 1223 1226 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Granulocyte recruitment is a primary finding in severe respiratory virus infection; activation of granulocytes can result in the release of proinflammatory cytokines and proteolytic enzymes that can contribute to the ongoing lung damage [33-37]. Interestingly, although neutrophils are recruited to the lung parenchyma in response to CCL3 via coordination by IFNgamma, these cytokines alone clearly are not sufficient to induce the inflammatory state that ultimately promotes lung damage and respiratory failure. Thus, despite our findings demonstrating improved survival from PVM infection with CCR1 blockade [15], and those of He and colleagues [38], who likewise demonstrated that CCR1 antagonism provided protection against neutrophil-mediated lung injury in a mouse model of acute pancreatitis, the results presented here, in which we observe neutrophil recruitment but minimal clinical disease, suggest that neutrophil recruitment and neutrophil activation are to some extent distinct and discrete signaling events. It will be crucial to identify the proinflammatory mediators that activate and well as those that recruit neutrophils in order to have a complete picture of the proinflammatory state characteristic of PVM infection.
###end p 35
###begin p 36
###xml 279 281 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 548 549 540 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 550 551 542 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 103 107 <span type="species:ncbi:10090">mice</span>
###xml 175 178 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 574 577 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
The experimental studies performed in this manuscript utilize both IFNgamma and IFNgammaR gene-deleted mice, which are in BALB/c and C57BL/6 background strains, respectively. PVM infection has been explored systematically in several inbred strains of mice by Anh and colleagues [39] who determined that the C57BL/6 strain is somewhat more resistant to infection than BALB/c, but that both of these inbred strains can ultimately succumb to the sequelae of severe disease. We have used both of these strains extensively for our studies (reviewed in [7-9]) and both respond to PVM infection with robust virus replication in lung tissue, granulocyte recruitment and local production of proinflammatory cytokines, including CCL3 and IFNgamma; no systematic differences, other than the aforementioned susceptibility to infection, have been detected.
###end p 36
###begin p 37
###xml 209 211 205 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 212 214 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 215 217 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 218 220 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 573 575 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 904 913 888 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 914 916 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1011 1013 991 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1092 1094 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1184 1186 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1486 1493 1458 1465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1671 1678 1639 1646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ex vivo</italic>
###xml 1940 1942 1904 1906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1967 1993 1931 1957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis</italic>
###xml 45 50 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 152 168 <span type="species:ncbi:227859">SARS coronavirus</span>
###xml 174 207 <span type="species:ncbi:11250">human respiratory syncytial virus</span>
###xml 886 891 <span type="species:ncbi:10090">mouse</span>
###xml 1110 1115 <span type="species:ncbi:9606">human</span>
###xml 1204 1209 <span type="species:ncbi:9606">human</span>
###xml 1374 1379 <span type="species:ncbi:10090">mouse</span>
###xml 1568 1572 <span type="species:ncbi:10090">mice</span>
###xml 1967 1993 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 2046 2050 <span type="species:ncbi:10090">mice</span>
Both CCL3 and IFNgamma have been detected in human studies and in mouse models of other severe respiratory virus infections, including avian influenza, SARS coronavirus, and human respiratory syncytial virus [17,18,40-47], although the potential for interplay between these specific signaling pathways has not been considered previously. Our data suggest that that IFNgamma and CCL3 signaling pathways, both crucial features of the response to pneumovirus infection, interact in a hierarchical fashion, as IFNgamma does not elicit neutrophil recruitment on its own [Figure 5A], but is crucial for CCL3 to function effectively. Interactions between IFNgamma and CCL3 may occur at the level of signal transduction, or via alterations to the neutrophil itself. As has been documented clearly, CCL3 can function alone to induce changes in calcium concentration and chemotactic responses in mouse neutrophils in vitro [48]. The current literature on interactions of IFNgamma with granulocytes was recently reviewed [49]. Among the possibilities that may address our findings, Hansen and Finbloom [50] reported that human neutrophils express IFNgamma receptors and Bonecchi and colleagues [51] have shown that human neutrophils respond to IFNgamma with increased expression of a variety of mediators and receptors, including the primary CCL3 receptor, CCR1. It is unclear whether mouse neutrophils respond in a similar fashion, and whether or not these defined molecular responses take place in vivo, although we have shown here that neutrophils from IFNgammaR gene-deleted mice express transcripts for CCR1 and mobilize intracellular calcium in response to CCL3 when examined ex vivo. We have not yet explored the possibility that the IFNgamma coordinates neutrophil recruitment in response to CCL3 in a more indirect fashion, possibly via one or more intermediary cytokines. An example of this phenomenon was reported by Khader and colleagues [52], who demonstrated that Mycobacterium tuberculosis-infected dendritic cells from IL-12p40 gene-deleted mice that were unresponsive to a CCL19 gradient were also overproducing the cytokine IL-10. Most intriguing, addition of IL-10 to wild-type dendritic cells reproduced the inhibited chemotaxis response.
###end p 37
###begin title 38
Conclusion
###end title 38
###begin p 39
###xml 302 310 298 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 94 97 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 169 174 <span type="species:ncbi:10090">mouse</span>
###xml 188 191 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
In summary, we demonstrate here that CCL3, a proinflammatory mediator produced in response to RSV and shown to be a crucial in recruiting neutrophils in response to the mouse pneumovirus, PVM, functions via a hierarchical relationship with IFNgamma. Specifically, CCL3 recruits neutrophils to the lung in vivo only in coordination with IFNgamma-mediated signaling pathways. The mechanism via which IFNgamma modulates neutrophil responses to CCL3 is an intriguing subject for future exploration.
###end p 39
###begin title 40
Methods
###end title 40
###begin title 41
Microarray analysis
###end title 41
###begin p 42
###xml 65 67 65 67 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Generation of gene microrarray data was as described previously [12]. Data collected were evaluated using the microarray software analysis package Genespring GX 7.3. The 'find similar' function was used to inspect all 45,101 transcript profiles in order to detect kinetic profiles similar to that of IFNgamma. The minimum correlation to be considered a similar profile was set at 0.900. The higher the correlation coefficient (maximum 1.000 for complete overlap), the more similar the gene expression profiles.
###end p 42
###begin title 43
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse, virus and vector stocks
###end title 43
###begin p 44
###xml 155 157 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 239 241 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 508 510 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 982 985 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11 </sup>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 233 237 <span type="species:ncbi:10090">mice</span>
###xml 429 432 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 513 517 <span type="species:ncbi:10090">Mice</span>
###xml 617 620 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 876 880 <span type="species:ncbi:10090">mice</span>
###xml 993 998 <span type="species:ncbi:10090">mouse</span>
###xml 1019 1023 <span type="species:ncbi:10090">mice</span>
###xml 1204 1208 <span type="species:ncbi:10090">mice</span>
###xml 1237 1243 <span type="species:ncbi:10090">murine</span>
###xml 1335 1339 <span type="species:ncbi:9913">calf</span>
BALB/c and C57BL/6 mice were purchased from Taconic Laboratories (Germantown, NY and Rockville, MD). Homozygous IFNgamma gene-deleted (IFNgamma -/-) mice [53] on a BALB/c background and IFNgamma receptor gene-deleted (IFNgammaR -/-) mice [54] on a C57BL/6 background were purchased from Jackson Laboratories, Bar Harbor, ME. All animal studies were performed as per approved protocols CHUA #634 (SUNY Upstate) or LAD 8E (NIAID). PVM strain J3666 was passaged, stored and quantitated as described previously [13]. Mice were anaesthetized and inoculated by intranasal challenge with 30 - 100 plaque forming units (pfu) PVM also as previously described. For challenge with recombinant vectors (described as follows), dilutions of secondary stock aliquots of vCCL3 and vctrl (described in the section to follow) were prepared in RPMI cell culture medium. Under brief anaesthesia, mice were inoculated with 150 mul of stock (50 mul/dose x 3 doses) to achieve challenges of 1.0 - 1.5 x 1011 pfu per mouse. On days indicated, mice in each challenge group were sacrificed by cervical dislocation and bronchoalveolar lavage (BAL) fluid, total lung protein and total lung RNA were harvested. For some experiments, mice received 15 mug recombinant murine IFNgamma (R&D Systems, Minneapolis, MN) diluted in tissue culture medium (RPMI + 10% fetal calf serum) or tissue culture medium (vehicle) via intraperitoneal injection one day prior to intranasal challenge with the vCCL3 or vctrl which yielded 323 +/- 28 pg IFNgamma/mg lung on day 4 post-inoculation.
###end p 44
###begin title 45
###xml 41 43 37 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
Flow cytometric determination of IFNgamma+ NK and T cells in mouse lung tissue
###end title 45
###begin p 46
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 573 575 566 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 1050 1052 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1592 1593 1573 1574 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1614 1616 1595 1597 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1622 1624 1603 1605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1669 1670 1650 1651 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1675 1676 1656 1657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1918 1920 1899 1901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 78 81 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 342 346 <span type="species:ncbi:9913">calf</span>
Whole lungs of BALB/c mice (uninfected or day 6 after inoculation with 10 pfu PVM, n = 5 per datapoint) were cut into ~3 mm3 pieces in HBSS buffer (Invitrogen) and pressed through a 100 micron cell strainer (BD Biosciences, San Jose, CA) to obtain single cell suspensions. Cells were suspended in RPMI-1640 medium supplemented with 10% fetal calf serum, 2 mM glutamine, 100 U/mL penicillin, 100 U/mL streptomycin, 50 muM 2-mercaptoethanol, 1 mM sodium pyruvate, and nonessential amino acids (all from Invitrogen) and incubated for 6 hrs at 37degreesC at a density of 1 x 106 cells/ml with 1 muM ionomycin, 20 ng/ml phorbol-12-myristate acetate (EMD Biosciences, San Diego, CA) and 10 mug/ml brefeldin A (Sigma-Aldrich Co., St. Louis, MO). DNAse I (Sigma) was added for 5 minutes and then cells were washed once and stained with violet LIVE/DEAD Fixable Dead Cell stain (Invitrogen) for 30 minutes on ice, washed in PBS, fixed in 4% PFA, and stored at -80degreesC until analysis. Intracellular cytokine staining was performed as described previously [55]. Cells were stained with I-Ad FITC, DX5-PE, CD3-PE-Cy5, CD4 PerCP/Cy5.5, IFNgamma PE-Cy7, and CD8 APC-Cy7 (BD Biosciences) in PBS with 0.1% BSA, 0.1% saponin (Sigma) and 5% nonfat dry skim milk. Controls were stained with isotype matched antibodies. Samples were acquired with a 4-laser LSR II flow cytometer (BD Biosciences) and analyzed on FlowJo software (Tree Star, Inc., San Carlos, CA). Viable lymphocytes were identified by typical forward and side scatter and negative staining for LIVE/DEAD violet. T cells were identified as I-A-, CD3+ and either CD4+ or CD8+ as indicated; NK cells were identified as I-A-, CD3-, DX5+. Quadrant statistical markers were based on corresponding isotype matched controls. Samples consisted of a known fraction (typically 1/4) of the cells obtained from a whole lung, and the entire sample was analyzed (typically 2 - 4 x 105 events) yielding the absolute number of cells per lung.
###end p 46
###begin title 47
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Isolation of neutrophils from wild type and IFNgammaR-/- mice
###end title 47
###begin p 48
###xml 77 79 73 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Neutrophils were isolated from wild type and IFNgammaR-/- mice as described [56]. Briefly, 2 mL intraperitoneal injection of thioglycollate was administered and 4 hours later, mice were sacrificed and cells were harvested by peritoneal flush with 10 mL PBS (without calcium or magnesium). Cells were washed, red blood cells lysed with distilled water, and viability determined at >95% by trypan blue exclusion. Further isolation via Ficoll/Hypaque density gradient centrifugation yielded neutrophil purities of 85 - 99% as determined by modified Giemsa staining of cytospin preparations.
###end p 48
###begin title 49
Absolute quantification of CCR1 expression
###end title 49
###begin p 50
###xml 99 101 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 200 203 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">st </sup>
###xml 896 898 892 894 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9 </sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 241 244 <span type="species:ncbi:11866?0.5863095238095238|species:ncbi:12321?0.21726190476190477">AMV</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 632 637 <span type="species:ncbi:10090">Mouse</span>
###xml 677 682 <span type="species:ncbi:10090">mouse</span>
Total RNA was isolated from neutrophils elicited from wild type and IFNgammaR -/- mice using the RT2 qPCR-Grade RNA Isolation Kit (SuperArray Bioscience Corporation). The cDNA was prepared using the 1st strand cDNA Synthesis Kit for RT-PCR (AMV; Roche Applied Science). QPCR was performed using the TaqMan Universal PCR Maser Mix (Applied BioSystems) with primer-probe pairs for GAPDH (TaqMan Rodent GAPDH Control Reagents VIC probe Applied Biosysystems) or CCR1 (chemokine (C-C motif) receptor 1 Mm00438260_s1 FAM labled, Applied Biosystems). The standard curve for mouse GAPDH included serial dilutions of the DECA template GAPDH-Mouse probe (Ambion); the standard curve for mouse CCR1 included serial dilutions of the coding sequence (GenBank Accession # ) in pCEP4. Reactions were run in triplicate in the 7500 RealTime PCR System (Applied Biosystems); data presented as copies of CCR1 per 109 copies GAPDH.
###end p 50
###begin title 51
Intracellular calcium measurements
###end title 51
###begin p 52
###xml 174 176 174 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 196 198 196 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
Intracellular calcium measurements were performed in a Benchtop Scanning Fluorometer and Integrated Fluid Transfer Workstation (Flexstation; Molecular Devices) as described [56]. Briefly, 2.5 x 105 thioglycollate-elicited neutrophils were suspended in 100 mul of Hank's buffered saline solution with 20 mM HEPES and 100 mul fluorescent dye (FLIPPER calcium 3 assay kit component A; Molecular Devices) in a 96 well plate. The cells were incubated at 37degreesC for 30 minutes, centrifuged for 5 minutes, and challenged with various concentrations of CCL3, buffer alone (negative control) or f-MLF (positive control). Changes in intracellular calcium concentration were recorded as relative fluorescence units (RFU).
###end p 52
###begin title 53
Construction vCCL3 and control (vctrl) overexpression vectors
###end title 53
###begin p 54
###xml 444 448 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pme </italic>
###xml 474 482 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 850 854 847 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pac </italic>
###xml 986 993 983 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1314 1317 1311 1314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">12 </sup>
###xml 191 197 <span type="species:ncbi:10090">murine</span>
###xml 474 481 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Generation of overexpression vectors was accomplished using the commercially available AdEasy XL vector system (Stratgene, La Jolla CA) according to the manufacturer's instructions. Briefly, murine CCL3 (GenBank Accesion No. ) was ligated into the multiple cloning site of the shuttle vector, pShuttleCMV; the corresponding control plasmid, containing the beta-galactosidase gene, was supplied with the kit. The constructs were linearized with Pme I and transformed into an E. coli strain, () which contains the replication-incompetent pAD-1 backbone. Transformants were selected for kanamycin resistance, and recombinants subsequently identified by restriction digestion. Once recombinants were identified, they were produced in bulk using the recombination-deficient bacterial strain, XL-10 Gold. Purified recombinant plasmid DNA was digested with Pac I to expose inverted terminal repeats and used to transfect AD-293 cells in which the deleted viral assembly genes are complemented in vivo. The resulting constructs, vctrl and vCCL3 were harvested from the transfected AD-293 cells when more than 90% of the monolayer exhibited cytopathic effects. Secondary stocks were produced in a similar fashion. Titration was performed by standard plaque assay. The concentration of secondary stocks reached titers of ~1012 pfu/ml for each construct. Viral stocks were stored at -80degreesC prior to use.
###end p 54
###begin title 55
Bronchoalveolar lavage (BAL) and differential cell counts
###end title 55
###begin p 56
###xml 59 63 <span type="species:ncbi:10090">mice</span>
###xml 159 165 <span type="species:ncbi:9913">bovine</span>
###xml 242 247 <span type="species:ncbi:10090">mouse</span>
At time points indicated, BAL fluids were harvested from 5 mice by trans-tracheal instillation and removal of pre-chilled phosphate-buffered saline with 0.25% bovine serum albumin (BSA; 0.80 ml instillation with recovery of 0.5 to 0.6 ml per mouse). Neutrophil counts were determined by visual inspection of methanol-fixed cytospin preparations stained with modified Giemsa (DiffQuik, Fisher Scientific, Pittsburgh PA).
###end p 56
###begin title 57
Chemokine and cytokine determinations
###end title 57
###begin p 58
###xml 107 109 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 121 125 <span type="species:ncbi:10090">mice</span>
###xml 280 286 <span type="species:ncbi:9913">bovine</span>
Concentrations of CCL3 and IFNgamma were determined in BAL fluid (pg/ml) isolated as previously described [13] from five mice per datapoint, using commercially available ELISA kits (R&D Systems, Minneapolis, MN). Total protein was determined the Bradford colorimetric assay using bovine serum albumin standards
###end p 58
###begin title 59
Gross and microscopic pathology and immunohistochemical detection of CCL3
###end title 59
###begin p 60
###xml 280 287 280 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 335 339 <span type="species:ncbi:9925">goat</span>
###xml 426 432 <span type="species:ncbi:9986">rabbit</span>
###xml 438 442 <span type="species:ncbi:9925">goat</span>
Paraffin blocks of formalin-fixed lung tissue from mice challenged with vctrl or vCCL3 were paraffin-embedded and sectioned. Standard hematoxylin and eosin staining of formalin-fixed tissue was performed by American Histolabs (Gaithersburg, MD). To detect CCL3 protein expression in situ, slides were incubated with a 1:50 dilution of goat anti-CCL3 (R&D Systems, Minneapolis, MN) followed by a 1:400 dilution of biotinylated rabbit anti-goat Ig and developing reagents (performed by Histoserv, Inc., Germantown, MD).
###end p 60
###begin title 61
Virus titer
###end title 61
###begin p 62
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 172 174 172 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9 </sup>
###xml 51 54 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
###xml 154 157 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Quantitative reverse transcriptase PCR to document PVM titer in mouse lung tissue was as described previously [57]. Datapoints are presented as copies of PVM SH gene per 109 copies GAPDH.
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
Experimental datapoints were from triplicate samples, experiments replicated two to three times. Data were evaluated by Student's t-test or Mann-Whitney U-test as appropriate.
###end p 64
###begin title 65
Abbreviations
###end title 65
###begin p 66
###xml 95 98 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
###xml 100 123 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 125 128 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 130 157 <span type="species:ncbi:12814">respiratory syncytial virus</span>
CCL3: CC chemokine ligand 3; IFNgamma: interferon-gamma; IFNgammaR: interferon-gamma receptor; PVM: pneumonia virus of mice; RSV: respiratory syncytial virus; CCR1: CC chemokine receptor 1; BAL: bronchoalveolar lavage; betagal: beta galactosidase; NK: natural killer; CCL19: CC chemokine ligand 19; PFU: plaque forming units; RFU: relative fluorescence units.
###end p 66
###begin title 67
Authors' contributions
###end title 67
###begin p 68
###xml 225 230 <span type="species:ncbi:10090">mouse</span>
 CB contributed to the initial design of the CCL3 overexpression studies and carried out the experimental work. CP contributed to the design of the virus infection studies and carried out the experimental work, also purified mouse neutrophils and determined CCR1 expression by quantitative RT-PCR. KD contributed to the design of the virus infection and neutrophil purification studies, reviewed the manuscript and assisted in design of the display items. JG assisted with the neutrophil purification protocol and performed the calcium transient studies. CP and BF designed and executed of the flow cytometry and intracellular cytokine staining studies. JD designed and provided direct overview of the CCL3 overexpression studies, and wrote the first draft of the manuscript. HR designed and provided direct overview of the virus infection studies, compiled the subsequent and final drafts of the manuscript and figures and oversaw the manuscript submission and revision.
###end p 68
###begin p 69
All authors read and approved the final manuscript.
###end p 69
###begin title 70
Author Information
###end title 70
###begin p 71
###xml 450 473 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 475 478 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
 Joseph B. Domachowske, M. D. is Professor of Pediatrics, Microbiology and Immunology at SUNY Upstate Medical University, Syracuse, New York. Helene F. Rosenberg, M. D. is Senior Investigator and Section Chief in the Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Drs. Domachowske and Rosenberg have collaborated extensively, and together have developed the pneumonia virus of mice (PVM) model for the study of the sequelae severe respiratory virus infection in a rodent host.
###end p 71
###begin title 72
Acknowledgements
###end title 72
###begin p 73
###xml 118 126 <span type="species:ncbi:9606">Children</span>
The authors thank Ms. Leslie Pesnicak for assistance with the intraperitoneal inoculations. Grant support provided by Children's Miracle Network of NY to JBD and NIAID DIR funding to HFR.
###end p 73
###begin article-title 74
Acute respiratory distress syndrome and pneumonia: a comprehensive review of clinical data
###end article-title 74
###begin article-title 75
###xml 46 73 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Acute respiratory distress syndrome caused by respiratory syncytial virus
###end article-title 75
###begin article-title 76
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Acute respiratory distress syndrome induced by avian influenza A (H5N1) virus in mice
###end article-title 76
###begin article-title 77
Clinical features and outcomes of severe acute respiratory syndrome and predictive factors for acute respiratory distress syndrome
###end article-title 77
###begin article-title 78
ARDS in SARS: cytokine mediators and treatment implications
###end article-title 78
###begin article-title 79
###xml 47 70 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 72 75 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Characteristics of the multiplication cycle of pneumonia virus of mice (PVM)
###end article-title 79
###begin article-title 80
###xml 4 27 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 55 82 <span type="species:ncbi:12814">respiratory syncytial virus</span>
The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention
###end article-title 80
###begin article-title 81
###xml 0 23 <span type="species:ncbi:11263">Pneumonia virus of mice</span>
Pneumonia virus of mice
###end article-title 81
###begin article-title 82
###xml 0 23 <span type="species:ncbi:11263">Pneumonia virus of mice</span>
Pneumonia virus of mice: severe respiratory infection in a natural host
###end article-title 82
###begin article-title 83
Immunization strategies for the prevention of pneumovirus infections
###end article-title 83
###begin article-title 84
###xml 80 107 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection
###end article-title 84
###begin article-title 85
###xml 62 85 <span type="species:ncbi:11263">pneumonia virus of mice</span>
###xml 87 90 <span type="species:ncbi:11263?0.47540983606557374">PVM</span>
Respiratory dysfunction and proinflammatory chemokines in the pneumonia virus of mice (PVM) model of viral bronchiolitis
###end article-title 85
###begin article-title 86
The chemokine macrophage-inflammatory protein-1alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection
###end article-title 86
###begin article-title 87
Altered pathogenesis of severe pneumovirus infection in response to combined antiviral and specific immunomodulatory agents
###end article-title 87
###begin article-title 88
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Functional antagonism of chemokine receptor CCR1 reduces mortality in acute pneumovirus infection in vivo
###end article-title 88
###begin article-title 89
###xml 43 48 <span type="species:ncbi:9606">Human</span>
Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by Phytohemagglutinin
###end article-title 89
###begin article-title 90
###xml 44 51 <span type="species:ncbi:9606">infants</span>
Inflammatory profile in nasal secretions of infants hospitalized with acute lower airway tract infections
###end article-title 90
###begin article-title 91
###xml 73 94 <span type="species:ncbi:162145">human metapneumovirus</span>
###xml 96 123 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 147 154 <span type="species:ncbi:9606">infants</span>
Cytokine profiles in the respiratory tract during primary infection with human metapneumovirus, respiratory syncytial virus, or influenza virus in infants
###end article-title 91
###begin article-title 92
###xml 7 34 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 52 59 <span type="species:ncbi:9606">infants</span>
Severe respiratory syncytial virus bronchiolitis in infants is associated with reduced airway interferon gamma and substance P
###end article-title 92
###begin article-title 93
###xml 39 46 <span type="species:ncbi:9606">infants</span>
Reduced interferon-gamma production in infants with bronchiolitis and asthma
###end article-title 93
###begin article-title 94
###xml 77 84 <span type="species:ncbi:9606">infants</span>
###xml 97 124 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Reduced interferon-gamma expression in peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease
###end article-title 94
###begin article-title 95
###xml 37 64 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Local interferon-gamma levels during respiratory syncytial virus lower respiratory tract infection are associated with disease severity
###end article-title 95
###begin article-title 96
###xml 46 73 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 6 12 <span type="species:ncbi:9606">infant</span>
###xml 13 40 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 42 45 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 113 116 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Human infant respiratory syncytial virus (RSV) - specific type 1 and 2 cytokine responses ex vivo during primary RSV infection
###end article-title 97
###begin article-title 98
###xml 89 116 <span type="species:ncbi:12814">respiratory syncytial virus</span>
IFN-gamma production during initial infection determines the outcome of reinfection with respiratory syncytial virus
###end article-title 98
###begin article-title 99
###xml 5 32 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 34 37 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
###xml 146 152 <span type="species:ncbi:10090">murine</span>
###xml 153 156 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model
###end article-title 99
###begin article-title 100
###xml 0 27 <span type="species:ncbi:12814">Respiratory syncytial virus</span>
Respiratory syncytial virus-induced immunoprotection and immunopathology
###end article-title 100
###begin article-title 101
###xml 36 63 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Role for innate IFNs in determining respiratory syncytial virus immunopathology
###end article-title 101
###begin article-title 102
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Activation and inactivation of antiviral CD8 T cell responses during murine pneumovirus infection
###end article-title 102
###begin article-title 103
###xml 70 93 <span type="species:ncbi:11263">pneumonia virus of mice</span>
The role of T cells in virus control and disease after infection with pneumonia virus of mice
###end article-title 103
###begin article-title 104
Requirement of MIP-1 alpha for an inflammatory response to viral infection
###end article-title 104
###begin article-title 105
###xml 102 114 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 102 125 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection
###end article-title 105
###begin article-title 106
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Bronchoalveolar lavage fluids of ventilated patients with acute lung injury activate NF-kappaB in alveolar epithelial cell line: role of reactive oxygen/nitrogen species and cytokines
###end article-title 106
###begin article-title 107
Early alterations in neutrophil activation are associated with outcome in acute lung injury
###end article-title 107
###begin article-title 108
Effects of catecholamines on kinase activation in lung neutrophils after hemorrhage or endotoxemia
###end article-title 108
###begin article-title 109
Natural inhibitors of neutrophil function in acute respiratory distress syndrome
###end article-title 109
###begin article-title 110
Interleukin-6 augments neutrophil cytotoxic potential via selective enhancement of elastase release
###end article-title 110
###begin article-title 111
###xml 61 65 <span type="species:ncbi:10090">mice</span>
Treatment with BX471, a nonpeptide CCR1 antagonist, protects mice against acute pancreatitis-associated lung injury by modifying neutrophil recruitment
###end article-title 111
###begin article-title 112
###xml 86 91 <span type="species:ncbi:10090">mouse</span>
Differential resistance/susceptibility patterns to pneumovirus infection among inbred mouse strains
###end article-title 112
###begin article-title 113
###xml 41 48 <span type="species:ncbi:9606">infants</span>
###xml 61 88 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis
###end article-title 113
###begin article-title 114
Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation
###end article-title 114
###begin article-title 115
###xml 51 59 <span type="species:ncbi:9606">patients</span>
An interferon-gamma related cytokine storm in SARS patients
###end article-title 115
###begin article-title 116
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice
###end article-title 116
###begin article-title 117
###xml 85 93 85 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 29 74 <span type="species:ncbi:227859">severe acute respiratory syndrome coronavirus</span>
Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro
###end article-title 117
###begin article-title 118
###xml 19 24 <span type="species:ncbi:9606">human</span>
Pathology of fatal human infection associated with avian influenza A H5N1 virus
###end article-title 118
###begin article-title 119
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice
###end article-title 119
###begin article-title 120
###xml 106 111 <span type="species:ncbi:9606">human</span>
Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses
###end article-title 120
###begin article-title 121
###xml 103 107 <span type="species:ncbi:10090">mice</span>
Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1
###end article-title 121
###begin article-title 122
Interferon-gamma activation of polymorphonuclear neutrophil function
###end article-title 122
###begin article-title 123
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 99 104 <span type="species:ncbi:9606">human</span>
Characterization of the interaction between recombinant human interferon-gamma and its receptor on human polymorphonuclear leukocytes
###end article-title 123
###begin article-title 124
###xml 88 93 <span type="species:ncbi:9606">human</span>
Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-g in human neutrophils
###end article-title 124
###begin article-title 125
###xml 84 111 84 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mycobacterium tuberculosis </italic>
###xml 84 110 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection
###end article-title 125
###begin article-title 126
###xml 44 48 <span type="species:ncbi:10090">mice</span>
Multiple defects of immune cell function in mice with disrupted interferon-gamma genes
###end article-title 126
###begin article-title 127
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Immune response in mice that lack the interferon-gamma receptor
###end article-title 127
###begin article-title 128
Unit 6.24, Detection of intracellular cytokines by flow cytometry
###end article-title 128
###begin article-title 129
###xml 64 69 <span type="species:ncbi:10090">mouse</span>
F2L, a peptide derived from heme-binding protein, chemoattracts mouse neutrophils by specifically activating Fpr2, the low-affinity N-formylpeptide receptor
###end article-title 129
###begin article-title 130
###xml 39 44 <span type="species:ncbi:10090">mouse</span>
###xml 153 157 <span type="species:ncbi:10090">mice</span>
Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice
###end article-title 130

